title: Impact of the NCCN biomarkers compendium on managed care pharmacy.
authors: Global Health Economics Outcomes Research, Xcenda, AmerisourceBergen Specialty Group, Palm Harbor, FL 34685, USA. melissa.denno@xcenda.com
authors: Melissa S
authors: MS
authors: Denno
authors: Loreen M
authors: LM
authors: Brown
authors: James H
authors: JH
authors: Jackson
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D003657:Decision Making; D015870:Gene Expression; D006801:Humans; D008329:Managed Care Programs / Q000458:organization & administration*; D008495:Medical Oncology / Q000379:methods; D025202:Molecular Diagnostic Techniques; D009154:Mutation; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D010593:Pharmaceutical Services / Q000458:organization & administration*; D017410:Practice Guidelines as Topic
chemical_list: D014408:Biomarkers, Tumor